Medicenna Therapeutics Investor Relations Material
Latest events
AGM 2023
Medicenna Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Medicenna Therapeutics Corp
Access all reports
Medicenna Therapeutics Corp. is a clinical stage immunotherapy company engaged in the development and commercialization of superkines for the treatment of cancer and other diseases. Medicenna Therapeutics Corp., was founded in 2015 and is headquartered in Toronto, Canada.
Latest articles
Companies That Had Their IPO in 2023: Cautious Optimism
The cautiously optimistic market in 2023 saw stocks rebounded upwards, and interest in IPOs picked up from the previous year.
15 Apr 2024
Puig's 2024 IPO: Paco Rabanne, Jean Paul Gaultier, and Beyond
Explore Puig's journey from its 1914 inception to a 2024 IPO, showcasing its growth, strategic acquisitions, and impact in the beauty and fashion industry.
15 Apr 2024
Alphabet's Unstoppable Rise: From Stanford to Global Tech Leader
Discover Alphabet's rise from a university project to a global tech leader, highlighting its growth, diversification, and visionary leadership.
15 Apr 2024
Ticker symbol
Country
🇨🇦 Canada